Portal de Periódicos da CAPES

An unusual presentation of pemphigus foliaceus following COVID‐19 vaccination

2021; Wiley; Volume: 63; Issue: 1 Linguagem: Inglês

10.1111/ajd.13755

1440-0960

Angelyn Chen Yin Lua, Felicia Li Ling Ong, Karen Jui Lin Choo, Yi Wei Yeo, Choon Chiat Oh,

Urticaria and Related Conditions

Australasian Journal of DermatologyVolume 63, Issue 1 p. 128-130 Letter to the Editors An unusual presentation of pemphigus foliaceus following COVID-19 vaccination Angelyn Chen Yin Lua, Corresponding Author Angelyn Chen Yin Lua [email protected] orcid.org/0000-0001-8065-4642 Department of Dermatology, Singapore General Hospital, Singapore City, SingaporeSearch for more papers by this authorFelicia Li Ling Ong, Felicia Li Ling Ong Department of Dermatology, Singapore General Hospital, Singapore City, SingaporeSearch for more papers by this authorKaren Jui Lin Choo, Karen Jui Lin Choo Department of Dermatology, Singapore General Hospital, Singapore City, Singapore Duke-NUS Medical School, Singapore City, SingaporeSearch for more papers by this authorYi Wei Yeo, Yi Wei Yeo Department of Dermatology, Singapore General Hospital, Singapore City, Singapore Duke-NUS Medical School, Singapore City, SingaporeSearch for more papers by this authorChoon Chiat Oh, Choon Chiat Oh orcid.org/0000-0002-4769-8595 Department of Dermatology, Singapore General Hospital, Singapore City, Singapore Duke-NUS Medical School, Singapore City, SingaporeSearch for more papers by this author Angelyn Chen Yin Lua, Corresponding Author Angelyn Chen Yin Lua [email protected] orcid.org/0000-0001-8065-4642 Department of Dermatology, Singapore General Hospital, Singapore City, SingaporeSearch for more papers by this authorFelicia Li Ling Ong, Felicia Li Ling Ong Department of Dermatology, Singapore General Hospital, Singapore City, SingaporeSearch for more papers by this authorKaren Jui Lin Choo, Karen Jui Lin Choo Department of Dermatology, Singapore General Hospital, Singapore City, Singapore Duke-NUS Medical School, Singapore City, SingaporeSearch for more papers by this authorYi Wei Yeo, Yi Wei Yeo Department of Dermatology, Singapore General Hospital, Singapore City, Singapore Duke-NUS Medical School, Singapore City, SingaporeSearch for more papers by this authorChoon Chiat Oh, Choon Chiat Oh orcid.org/0000-0002-4769-8595 Department of Dermatology, Singapore General Hospital, Singapore City, Singapore Duke-NUS Medical School, Singapore City, SingaporeSearch for more papers by this author First published: 24 November 2021 https://doi.org/10.1111/ajd.13755Citations: 11 Conflict of interest: The authors have no conflicts of interest to declare. Funding: There is no financial interest to report. Informed consent: Written informed consent was obtained from the patient for the publication of this case report. Ethics approval: Ethics approval was not required for this case report with the patient's informed consent. We certify that the submission is original work and is not under review at any other publication. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet 2019 Sep 07; 394: 882–94. 10.1016/S0140-6736(19)31778-7 CASPubMedWeb of Science®Google Scholar 2Damiani G, Pacifico A, Pelloni F et al. The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? J. Eur. Acad. Dermatol. Venereol. 2021 Oct; 35: e645. 10.1111/jdv.17472 CASPubMedWeb of Science®Google Scholar 3Solimani F, Mansour Y, Didona D et al. Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2. J. Eur. Acad. Dermatol. Venereol. 2021 Oct; 35: e649. 10.1111/jdv.17480 CASPubMedWeb of Science®Google Scholar 4Thongprasom K, Pengpis N, Phattarataratip E et al. Oral pemphigus after COVID-19 vaccination. Oral. Dis. 2021 Sep 21. Early view. 10.1111/odi.14034 PubMedWeb of Science®Google Scholar 5Tomayko MM, Damsky W, Fathy R et al. Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination. J. Allergy. Clin. Immunol. 2021 Sep 1; 148: 750–1. 10.1016/j.jaci.2021.06.026 CASPubMedWeb of Science®Google Scholar 6James KA, Culton DA, Diaz LA. Diagnosis and clinical features of pemphigus foliaceus. Dermatol. Clin. 2011 Jul; 29: 405–12. 10.1016/j.det.2011.03.012 CASPubMedWeb of Science®Google Scholar 7Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell. Mol. Immunol. 2018 Jun; 15: 586–94. 10.1038/cmi.2017.151 CASPubMedWeb of Science®Google Scholar 8Théophile H, Arimone Y, Miremont-Salamé G et al. Comparison of three methods (Consensual Expert Judgement, Algorithmic and Probabilistic Approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre. Drug. Saf. 2010 Nov; 33: 1045–54. 10.2165/11537780-000000000-00000 PubMedWeb of Science®Google Scholar 9Agbabiaka TB, Savović J, Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug. Saf. 2008; 31: 21–37. 10.2165/00002018-200831010-00003 PubMedWeb of Science®Google Scholar 10Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 1981; 30: 239–45. 10.1038/clpt.1981.154 CASPubMedWeb of Science®Google Scholar Citing Literature Volume63, Issue1February 2022Pages 128-130 ReferencesRelatedInformation